Firas Badin, MD, Baptist Health
Articles
The Future of Lung Cancer Treatment
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Mesothelioma: A Look at DREAM3R and PrECOG Trial
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Trials in Limited-Stage Small-Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Treatment for Progressive Small-Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Treatment Options in Small–Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Recent Advances in Small-Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Treatment for PD-L1 High/Low/Negative Non–Small Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Understanding Immune Response in Non–Small Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Chemotherapy and Immunotherapy in Non–Small Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Treatment Options in PD-L1 Positive Non–Small Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Treatment Efficacy in Non–Small Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Frontline Treatment in Non–Small Cell Lung Cancer
Suresh S. Ramalingam, MD, Winship Cancer Institute;Firas Badin, MD, Baptist Health;Christine Bestvina, MD, University of Chicago;Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute;Stephen Liu, MD, Georgetown University School of Medicine
October 26th 2020Read More
Latest Updated Articles
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data
